Dr. Pamela A. (Martoglio) Smith joined Improved Pharma as COO in 2018. Previously, Dr. Smith was Vice President of Analytical Services for AMRI, where she was responsible for 300 employees at four global sites. One of those sites included SSCI, the cGMP contract research organization founded by Dr. Steve Byrn and Sally Byrn. She had a long history with SSCI, having joined it in 1999 as a Research Scientist specializing in vibrational spectroscopy and solid state method development. When SSCI was acquired by Aptuit in 2006, she assumed P&L responsibility for the analytical division of SSCI. In 2009, Dr. Smith was asked to become a Lean Six Sigma black belt and she generated over $2M in benefits during her tenure in this role. Eventually, she assumed the role of General Manager for SSCI, where she led the site to record performances for multiple years, culminating in the successful sale of SSCI to AMRI for $36M.
At Improved Pharma, Dr. Smith has operational and scientific responsibility, serving pharmaceutical clients with their solid-state or analytical needs. She has 30+ years of technical scientific experience spanning research and development and problem solving. Fields of focus include vibrational spectroscopy, microspectroscopy, patent litigation support, and synchrotron XRPD and PDF analysis. Dr. Smith has almost 100 publications and presentations and has received numerous awards over the years, including being recognized by the White House at the 2016 United State of Women Summit as a Changemaker, “extraordinary women who are creating change in our world- women who are doing great things”.